NCT00005069 Arsenic Trioxide in Treating Patients With Metastatic Kidney Cancer Status COMPLETED Phase PHASE2
NCT00005040 Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00005033 Trastuzumab in Treating Patients With Recurrent Osteosarcoma Status COMPLETED Phase PHASE2
NCT00004930 Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung Metastases Status COMPLETED Phase PHASE1
NCT00004929 Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer Status COMPLETED Phase PHASE1
NCT00004928 Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer Status COMPLETED Phase PHASE1
NCT00004927 BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy Status COMPLETED Phase PHASE1
NCT00004926 ILX23-7553 in Treating Patients With Solid Tumors That Have Not Responded to Previous Therapy Status COMPLETED Phase PHASE1
NCT00004925 Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced, Inflammatory, or Metastatic Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00004922 Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors Status COMPLETED Phase PHASE2
NCT00004891 PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During Surgery Status COMPLETED Phase NA
NCT00004250 Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By Surgery Status COMPLETED Phase PHASE2
NCT00004249 Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy Status COMPLETED Phase PHASE2
NCT00004245 Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE1
NCT00004238 10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00004215 Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia Status COMPLETED Phase PHASE2
NCT00004152 PET and CT Scans to Evaluate Patients With Stage III or Stage IV Melanoma Status COMPLETED Phase PHASE2
NCT00004113 Temozolomide in Treating Patients With Recurrent Malignant Glioma Status COMPLETED Phase PHASE2